Breaking News
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
February 21, 2019 - Overweight, obesity in adolescence associated with increased risk of renal cancer later in life
February 21, 2019 - BGU develops new AI platform for monitoring and predicting ALS progression
February 21, 2019 - Researchers discover a new promising target to improve HIV vaccines
February 21, 2019 - Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
February 21, 2019 - Gaming system helps with autism diagnosis
February 21, 2019 - Heart Disease: Six Things Women Should Know
February 21, 2019 - More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
February 21, 2019 - Researchers explore case studies focused on industries that kill more people than employed
February 21, 2019 - Only half of GP practice buildings are fit for purpose
February 21, 2019 - Intense exercise, fasting and hormones can enhance waste-protein removal, study shows
February 21, 2019 - Scientists can monitor brain activity to predict epileptic seizures few minutes in advance
February 21, 2019 - Study quantifies hepatic and intestinal mRNA expression of Ugt isoforms in rats
February 21, 2019 - ‘Apple-Shaped’ Body? ‘Pear-Shaped’? Your Genes May Tell
February 21, 2019 - Can we repair the brain? The promise of stem cell technologies for treating Parkinson’s disease
February 21, 2019 - Trump Plan To Beat HIV Hits Rough Road In Rural America
February 21, 2019 - PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms
February 21, 2019 - Trump plan to beat HIV hits rough road in rural America
February 21, 2019 - Eating blueberries every day could help decrease blood pressure
February 21, 2019 - ‘No Second Chances’ report calls for new measures to combat cardiovascular disease in Australia
February 21, 2019 - Mayo clinic researchers discuss local case studies of leprosy
February 21, 2019 - Scientists demonstrate key role of salt in allergic immune reactions
February 21, 2019 - Experts propose revising the criteria for diagnosis of Parkinson’s disease
February 21, 2019 - The med student and the machine
February 21, 2019 - Hey, Hey! Ho, Ho! Is Striking For School Nurses The Way To Go?
February 21, 2019 - Latest research encourages children to move out and learn through physical activity
February 21, 2019 - Proper oral hygiene and regular visits to dentist can promote heart health
February 21, 2019 - New, versatile technique for remote control of transplanted cells in Parkinson’s
February 21, 2019 - Why melanoma tumors in the brain may be worse?
February 21, 2019 - New project aims to improve lung disease care in Appalachia
February 21, 2019 - Drug increases melanin production in some people with albinism
February 21, 2019 - Over 1 in 3 adults miss the mark on protein, finds study
February 21, 2019 - CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
February 21, 2019 - A correlation between obesity and income has only developed in the past 30 years
New therapeutic drug monitoring service could benefit children with cancer

New therapeutic drug monitoring service could benefit children with cancer

image_pdfDownload PDFimage_print

Children with cancer are to benefit nationally from a service which for the first time will allow doctors to personalize their treatment.

The therapeutic drug monitoring service, developed by Newcastle University experts, allows clinicians to obtain vital information about how much chemotherapy individual young patients should receive.

Youngsters diagnosed with cancer, including infants in the first weeks of life, can be particularly hard to treat as it is difficult to know how much chemotherapy to give.

Doctors sometimes have to make tough decisions about the most appropriate dose of a drug, without enough scientific information to help them decide on the best course of action.

Drug monitoring

The service was set up at the request of doctors at the Great North Children’s Hospital, in Newcastle, UK, and other childhood cancer primary treatment centers around the UK.

It works by collecting blood samples after chemotherapy is administered on the first day of treatment. The samples are analyzed in real-time to measure individual patient drug exposure, with the results generated used to adjust dosing accordingly.

The amount of chemotherapy given over subsequent days is then set to ensure that the patient receives a dose that is most likely to be effective but without causing too much toxicity, such as sickness and diarrhea.

Professor Gareth Veal, from the Northern Institute for Cancer Research at Newcastle University, is leading the programme which is already benefitting many patients.

He said: “Establishing the correct dose of cancer treatment for very young patients has long presented a major clinical challenge as developmental physiological changes can markedly impact on the effect of a drug once it has been administered.

“If the patient is under-dosed then the tumor may not respond to treatment, whereas if the patient is overdosed then they are likely to experience more unwanted side effects of the drugs.

“It is difficult to predict what happens to a drug following administration in terms of how efficiently it is broken down and removed from the body.

“Our therapeutic drug monitoring service involves measuring drug levels in individual childhood cancer patients during treatment and modifying the dose of drug that they are given to help provide the best clinical outcome.”

Need for service

Before the service, clinicians would work out the infant or child’s chemotherapy dose by the patient’s weight and age, with a ‘one size fits all’ model

Dr Gail Halliday, Consultant Paediatric Oncologist at Newcastle Hospitals NHS Foundation Trust, said: “The therapeutic drug monitoring service has transformed the way young cancer patients are treated and the positive outcomes they have.

“Before it was something of a guessing game as to the most appropriate dose of chemotherapy for each child, whereas now we can be rest assured that what we are giving is correct.

“In the past, the risk factors were you either under-dosed and if the tumor came back it would be more difficult to cure, or you overdosed and the child suffered lasting effects from the toxicity.

“It is vital that we do everything we can to give each patient the best chance of responding effectively to treatment, whilst minimizing the chances of experiencing unwanted drug side effects.

“Now there is real confidence that we’re achieving a gold standard of care and it is thanks to the Newcastle University team that this is possible.”

Further research

The service has been running at the Great North Children’s Hospital for the past few years, but now the National Institute for Health Research has provided funding to Newcastle University to run a three year study to expand the service nationally.

Professor Veal said: “This will not only positively impact on patients recruited to the study, but will also generate data which will have a significant impact on future patient treatment through the provision of national guidelines for anti-cancer drugs in defined patient populations.”

The therapeutic drug monitoring service is a finalist in the Bright Ideas in Health Awards, which celebrates the achievements of those within the NHS, industry and academia to improve patient care, with the awards evening being held later this week.

Patient’s story

Little Blazej Sarnicki is lucky to be alive after the most challenging few years of his young life.

The five-year-old was diagnosed with aggressive Wilms’ tumors in both kidneys in 2016 and is now on dialysis three times a week after both organs were removed to save his life.

The youngster has been in intensive care at the Great North Children’s Hospital a number of times and it was touch and go as to whether he would survive. In the future he will need a kidney transplant.

Blazej was among the first to benefit from the therapeutic drug monitoring service as he required intensive chemotherapy and doctors needed to tailor his dose to his individual medical needs.

His mother, Monika, 38, a teacher, said: “It is fantastic to see how well Blazej is doing and it’s thanks to the treatment he received that he’s doing so well.

“We were devastated when Blazej was diagnosed with Wilms’ tumors as we had never heard of the disease and there were times when we thought we’d lose him.

“I know that the therapeutic drug monitoring service helped to give him the best-personalized treatment, and the medical team have worked incredibly hard to help Blazej.

“To have a service like this based in Newcastle is of great benefit to the North East and further afield.”

Blazej is back at school and enjoying life with his twin brother, Olivier, sister, Julia, nine, and parents Monika and Grezegorz.

Tagged with:

About author

Related Articles